169 related articles for article (PubMed ID: 29337178)
1. Multifocality as a prognostic factor in thyroid cancer: A meta-analysis.
Joseph KR; Edirimanne S; Eslick GD
Int J Surg; 2018 Feb; 50():121-125. PubMed ID: 29337178
[TBL] [Abstract][Full Text] [Related]
2. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients.
Kim KJ; Kim SM; Lee YS; Chung WY; Chang HS; Park CS
Ann Surg Oncol; 2015 Jan; 22(1):125-31. PubMed ID: 25092159
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.
Qu N; Zhang L; Ji QH; Chen JY; Zhu YX; Cao YM; Shen Q
World J Surg; 2015 Oct; 39(10):2459-70. PubMed ID: 26099728
[TBL] [Abstract][Full Text] [Related]
7. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.
Liu LS; Liang J; Li JH; Liu X; Jiang L; Long JX; Jiang YM; Wei ZX
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1327-1338. PubMed ID: 27645473
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
9. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
10. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis.
Geron Y; Benbassat C; Shteinshneider M; Or K; Markus E; Hirsch D; Levy S; Ziv-Baran T; Muallem-Kalmovich L
Thyroid; 2019 Apr; 29(4):513-522. PubMed ID: 30799769
[TBL] [Abstract][Full Text] [Related]
11. Unilateral Multifocality Is Not a Risk Factor for Recurrence After Thyroid Lobectomy: A Study of 1,684 Patients With Differentiated Thyroid Cancer.
Cho JS; Kim HK
In Vivo; 2023; 37(4):1802-1808. PubMed ID: 37369469
[TBL] [Abstract][Full Text] [Related]
12. Lateral lymph node metastasis in papillary thyroid carcinoma: A systematic review and meta-analysis for prevalence, risk factors, and location.
So YK; Kim MJ; Kim S; Son YI
Int J Surg; 2018 Feb; 50():94-103. PubMed ID: 29329789
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer.
Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
[TBL] [Abstract][Full Text] [Related]
14. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract][Full Text] [Related]
15. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
16. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Significance and Prognosis of Medullary Thyroid Microcarcinoma: A Meta-analysis.
Kim JH; Pyo JS; Cho WJ
World J Surg; 2017 Oct; 41(10):2551-2558. PubMed ID: 28451761
[TBL] [Abstract][Full Text] [Related]
18. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
20. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
